saikosaponin d has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Liu, Y; Xiang, Q | 1 |
1 other study(ies) available for saikosaponin d and Alloxan Diabetes
| Article | Year |
|---|---|
Saikosaponin d (SSD) alleviates diabetic peripheral neuropathy by regulating the AQP1/RhoA/ROCK signaling in streptozotocin-induced diabetic rats.
Topics: Animals; Aquaporin 1; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperalgesia; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Saponins; Signal Transduction; Streptozocin | 2023 |